Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) — Stock Score Summary

Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) has a MoatMap StockRank of 30/100 based on Quality (68/100), Value (21/100), and Momentum (29/100) factor scores. The current signal is SELL. Shenzhen Salubris is a solid domestic Chinese pharmaceutical company. However, it does not operate as a global CDMO with pricing power, and its growth is highly dependent on domestic Chinese healthcare policies and volume-based procurement risks.

Shenzhen Salubris Pharmaceuticals Co., Ltd. develops, manufactures, and markets specialty pharmaceuticals, with a core focus on cardiovascular, oncology, and anti-infective therapeutic areas. The company's competitive moat is anchored by its robust pipeline of innovative drugs, including its proprietary anti-hypertensive drug Allisartan Isoproxil, and its strong clinical sales network. It is a prominent player in China's transition from generic manufacturing to innovative drug development.

Key Financial Metrics

Price$4.64
Market Cap$5.5B
P/E (TTM)53.75
P/E (Forward)50.39
Price/Book3.93
Return on Equity7.4%
Return on Invested Capital6.9%
Debt/Equity2.59
Gross Margin75.0%
Operating Margin20.1%
Revenue Growth15.7%
Dividend Yield1.7%
Free Cash Flow$2M

Shenzhen Salubris Pharmaceuticals Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shenzhen Salubris Pharmaceuticals Co., Ltd.’s (002294.SZ) StockRank?
MoatMap’s StockRank for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is 30/100, with a Sell signal. It is a composite of Quality (68), Value (21), and Momentum (29) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shenzhen Salubris Pharmaceuticals Co., Ltd. have an economic moat?
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shenzhen Salubris Pharmaceuticals Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) is Sell, based on a StockRank of 30/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shenzhen Salubris Pharmaceuticals Co., Ltd. in?
Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks002294.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock